Rock Springs Capital Management LP 13D and 13G filings for Tempest Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:12 pm Sale |
2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 0 0.000% |
-823,654 (Position Closed) |
Filing |
| 2023-02-14 2:57 pm Unchanged |
2022-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 823,654 7.830% |
0 (Unchanged) |
Filing |
| 2022-01-03 4:15 pm Purchase |
2021-12-22 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 823,654 11.480% |
513,493 (+165.56%) |
Filing |
| 2021-07-15 4:31 pm Sale |
2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 310,161 4.670% |
-331,994 (-51.70%) |
Filing |
| 2021-07-08 4:25 pm Purchase |
2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 642,155 9.680% |
642,155 (New Position) |
Filing |